Bioavailability of 11 sulfisoxazole products in humans. 1976

G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer

Single lots of 11 commercially available 500-mg sulfisoxazole tablets were evaluated in vitro and in vivo. All products tested met USP XVIII specifications for weight variation and product assay. However, three products failed to meet the USP XVIII dissolution requirement. The only statistically significant difference observed between the 11 products was a lower peak plasma level exhibited by one product. No useful correlation was observed between the in vivo and in vitro studies for the dosage forms tested.

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013444 Sulfisoxazole A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. Sulfafurazole,Gantrisin,Gantrisin Pediatric,Neoxazoi,Sulfadimethyloxazole,Sulfafurazol FNA,Sulfasoxizole,Sulfisoxazole Diolamine,Sulfisoxazole, Ammonium Salt,Sulfisoxazole, Monolithium Salt,Sulfisoxazole, Monosodium Salt,Sulfisoxazole, Monosodium, Monomesylate Salt,Sulfisoxazole, Triammonium Salt,TL-azole,V-Sul,Ammonium Salt Sulfisoxazole,Diolamine, Sulfisoxazole,Monolithium Salt Sulfisoxazole,Monosodium Salt Sulfisoxazole,Pediatric, Gantrisin,TL azole,Triammonium Salt Sulfisoxazole,V Sul
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
January 1986, Pediatric infectious disease,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
May 1981, Journal of pharmaceutical sciences,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
August 1960, The Journal of pharmacology and experimental therapeutics,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
September 2016, Journal of pharmaceutical and biomedical analysis,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
March 1976, Journal of pharmaceutical sciences,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
September 1981, Journal of pharmaceutical sciences,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
July 1978, Journal of pharmaceutical sciences,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
January 1990, European journal of clinical pharmacology,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
September 1985, Chemical & pharmaceutical bulletin,
G W Slywka, and A P Melikian, and A B Straughn, and P L Whyatt, and M C Meyer
January 1978, Acta poloniae pharmaceutica,
Copied contents to your clipboard!